Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance

Transplantation
R ShapiraZ Ben-Ari

Abstract

There is very little information about hepatitis B virus (HBV) infection in children after liver transplantation. This is the first report of the addition of famciclovir in a child who developed lamivudine resistance.A 5-year-old boy who was serum HBsAg-negative and was not vaccinated against HBV underwent living-related liver transplantation for fulminant hepatitis A. The donor was his mother, who was serum HBcAb-positive. No immunoprophylaxis was administered. HBV infection developed after 18 months and was treated with 3 mg/kg daily of lamivudine. Serum alanine aminotransferase normalized and HBV DNA load decreased significantly. Sixteen months later, lamivudine resistance developed; a mutation (M552I) was confirmed by sequencing through the YMDD locus of the HBV polymerase gene. The addition of 750 mg daily of famciclovir led to seroconversion and the disappearance of serum HBV DNA. Lamivudine in combination with famciclovir might be a therapeutic option for HBV reinfection after liver transplantation, also in children. Suppression of viral replication to undetectable values is possible even in the lamivudine-resistant mutant.

References

Dec 16, 1993·The New England Journal of Medicine·D SamuelH Bismuth
Apr 1, 1993·Journal of Pediatric Gastroenterology and Nutrition·P LykavierisF Alvarez
Jan 1, 1996·Transplant International : Official Journal of the European Society for Organ Transplantation·G W HallerP Neuhaus
Jul 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D ColledgeT Shaw
Jul 1, 1996·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·M KrügerM P Manns
Nov 1, 1996·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·G McCaughanS Locarnini
Nov 20, 1998·The American Journal of Gastroenterology·S H HanR W Busuttil
Apr 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R PerrilloN Brown
Dec 9, 2000·Transplant International : Official Journal of the European Society for Organ Transplantation·D SeehoferP Neuhaus
Feb 15, 2001·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Z Ben-AriR Tur-Kaspa

❮ Previous
Next ❯

Citations

May 8, 2003·Current Gastroenterology Reports·Kathleen B Schwarz
Nov 25, 2004·Transplantation Proceedings·Z-X WangC-Y Zhang
Nov 27, 2002·Antiviral Chemistry & Chemotherapy·Xuefeng Liu, Raymond F Schinazi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Indian Journal of Pediatrics
Voranush Chongsrisawat, Yong Poovorawan
Pediatrics International : Official Journal of the Japan Pediatric Society
Bunyamin DikiciKenan Haspolat
Journal of Pediatric Gastroenterology and Nutrition
L ZancanE S d'Amore
Pediatrics International : Official Journal of the Japan Pediatric Society
Mukadder Ayşe SelimogluRaşit Vural Yagci
© 2022 Meta ULC. All rights reserved